Isorhamnetin Enhances the Radiosensitivity of A549 Cells Through Interleukin-13 and the NF-κB Signaling Pathway

Isorhamnetin Enhances the Radiosensitivity of A549 Cells Through Interleukin-13 and the NF-κB Signaling Pathway

Isorhamnetin (ISO), a naturally occurring plant flavonoid, is widely used as a phytomedicine. The major treatment modality for non-small-cell lung carcinoma (NSCLC) is radiotherapy. However, radiotherapy can induce radioresistance in cancer cells, thereby resulting in a poor response rate. Our resul...

Full description

Bibliographic Details
Main Authors: Yarong Du, Cong Jia, Yan Liu, Yehua Li, Jufang Wang, Kun Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Pharmacology
Subjects:
isorhamnetin
IL-13
NF-kB
radiosensitivity
radiotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.610772/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.610772/full

Similar Items